Therefore, large doses of insulin may be required in humans, and it has been reported that a high-dose oral insulin (67.5 mg daily) induced an immune response in genetically at-risk healthy children, which may be protective for T1DM, and no adverse event, such as hypoglycemia, was detected (Bonifacio et al., 2015). The gene discussed is INS; the disease is type 1 diabetes mellitus.